Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

With more than 71 million people chronically infected, hepatitis C virus (HCV) is one of the leading causes of liver disease and hepatocellular carcinoma. While efficient antiviral therapies have entered clinical standard of care, the development of a protective vaccine is still elusive. Recent stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Autores principales: Wrensch, Florian, Crouchet, Emilie, Ligat, Gaetan, Zeisel, Mirjam B., Keck, Zhen-Yong, Foung, Steven K. H., Schuster, Catherine, Baumert, Thomas F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021501/
https://ncbi.nlm.nih.gov/pubmed/29977246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01436
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares